Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Candesartan cilexetil, Atacand, Amias, Blopress, Ratacand, TCV 116, TCY 116

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 696Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/06/2025 Alembic Pharmaceuticals Limited
    India
    		 M-Peak Korea Co., Ltd. 20200213-209-J-339(3) Candesartan cilexetil 2020-07-29 Alembic Pharmaceuticals Limited (API Division-II) India Survey No. 144P1, 144P2, 144P3, 145P, 137, 138, 139, 140, Panelav, Tal-Halol, Dist.-Panchmahal, Gujarat state, India
    28/06/2025 Alembic Pharmaceuticals Limited
    India
    		 Ildong Pharmaceutical Co., Ltd. 20200213-209-J-339(2) Candesartan cilexetil 2020-07-21 Alembic Pharmaceuticals Limited (API Division-II) India Survey No. 144P1, 144P2, 144P3, 145P, 137, 138, 139, 140, Panelav, Tal-Halol, Dist.-Panchmahal, Gujarat State, India